People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bakx Therapeutics, Inc. | — | Biotechnology | Series B | $20.3M | $494.0M | 2021 |
| Red Queen Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $97.4M | 2021 |
Loren Walensky at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Loren Walensky on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 1 | 19 |
| Spiros Liras | 1 | 6 |
| Paul Da Silva Jardine | 1 | 3 |
| Ervis Gavathiotis | 1 | 1 |
| Jessie English | 1 | 1 |
| Sree Kant | 1 | 1 |
| Frances Toneguzzo | 1 | 1 |
| Yibing Shan | 1 | 1 |
| Phillippe Lopes-Fernandes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.